INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 46 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,000 | -99.9% | 8,000 | -99.9% | 0.00% | -100.0% |
Q2 2020 | $4,874,000 | -17.8% | 6,477,000 | -12.7% | 0.00% | 0.0% |
Q1 2020 | $5,932,000 | +23.5% | 7,415,000 | +55.6% | 0.00% | 0.0% |
Q4 2019 | $4,804,000 | -19.6% | 4,764,000 | -31.4% | 0.00% | 0.0% |
Q3 2019 | $5,975,000 | -7.9% | 6,948,000 | -4.5% | 0.00% | 0.0% |
Q2 2019 | $6,485,000 | +118.3% | 7,273,000 | +142.3% | 0.00% | – |
Q1 2019 | $2,971,000 | +2702.8% | 3,002,000 | +2510.4% | 0.00% | – |
Q4 2018 | $106,000 | +2550.0% | 115,000 | +2775.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | -99.7% | 4,000 | -99.7% | 0.00% | – |
Q1 2018 | $1,161,000 | +38600.0% | 1,449,000 | +36125.0% | 0.00% | – |
Q4 2017 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | -95.6% | 4,000 | -94.3% | 0.00% | – |
Q2 2017 | $68,000 | -94.4% | 70,000 | -94.6% | 0.00% | – |
Q1 2017 | $1,216,000 | -76.7% | 1,305,000 | -77.8% | 0.00% | -100.0% |
Q4 2016 | $5,228,000 | – | 5,866,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Silver Point Capital L.P. | 57,420,000 | $44,527,000 | 5.17% |
Birch Grove Capital LP | 10,003,000 | $7,934,000 | 4.14% |
PenderFund Capital Management Ltd. | 9,605,000 | $9,491,000 | 2.41% |
Context Capital Management, LLC | 9,887,000 | $7,671,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $45,738,000 | 0.90% |
DeepCurrents Investment Group LLC | 35,892,000 | $27,953,000 | 0.74% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 22,977,000 | $18,267,000 | 0.70% |
WHITEBOX ADVISORS LLC | 23,150,000 | $17,847,000 | 0.56% |
ADVENT CAPITAL MANAGEMENT /DE/ | 27,397,000 | $21,720,000 | 0.46% |
OAKTREE CAPITAL MANAGEMENT LP | 19,435,000 | $15,079,000 | 0.26% |